You are here:
Gavi’s two funding streams, innovative finance and direct contributions account for 31% and 69% respectively of the Vaccine Alliance’s overall funding portfolio.
Multi-year pledges and commitments are crucial to sustaining Gavi's ongoing programmes and its ability to fund new vaccines.
Public-private partnerships Corporations, private individuals & foundations play a vital role in meeting Gavi needs, accounting for 23% of 2000 to 2014 funding.
Cultivation of key public & private donor relationships, co-financing, shaping vaccine markets and mobilising civil society advocacy.
In 2014, more than 70 countries were co-financing new and underused vaccines supplied by Gavi. Their contributions totalled over US$ 80 million. More than 20 countries are projected to be fully self-financing their vaccines by 2020.
20 January 2016
Ebola: $5m vaccine deal announced
02 December 2015
Measles Outbreaks Are a Sign of Bigger Problems
29 October 2015
World Health Organisation right to be wary about first malaria vaccine
06 October 2015
Make vaccine coverage a key UN health indicator
22 August 2015
Vaccinations Bring Hope, Bracelets Deliver Reminders
The New York Times
03 March 2015
Ebola vaccine research in Africa
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
05 October 2012
GAVI Alliance CEO: Leadership Is About Vision and Responsibility, Not Power
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2016
modal window here